Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

David G McLeod; Peter Iversen; William A See; Thomas Morris; Jon Armstrong; Manfred P Wirth; Casodex Early Prostate Cancer Trialists' Group

doi:10.1111/j.1464-410X.2005.06051.x

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

David G McLeod, Peter Iversen, William A See, Thomas Morris, Jon Armstrong, Manfred P Wirth, Casodex Early Prostate Cancer Trialists' Group

252 Citations (Scopus)

Abstract

To evaluate, in the ongoing Early Prostate Cancer (EPC) trial programme, the efficacy and tolerability of bicalutamide 150 mg once daily in addition to standard care for localized or locally advanced, nonmetastatic prostate cancer.

Original language	English
Journal	BJU International
Volume	97
Issue number	2
Pages (from-to)	247-54
Number of pages	8
ISSN	1464-4096
DOIs	https://doi.org/10.1111/j.1464-410X.2005.06051.x
Publication status	Published - 1 Feb 2006

Access to Document

10.1111/j.1464-410X.2005.06051.x

Cite this

@article{f72d93b7cf8840baa2a063e440ee41f0,

title = "Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer",

abstract = "To evaluate, in the ongoing Early Prostate Cancer (EPC) trial programme, the efficacy and tolerability of bicalutamide 150 mg once daily in addition to standard care for localized or locally advanced, nonmetastatic prostate cancer.",

author = "McLeod, {David G} and Peter Iversen and See, {William A} and Thomas Morris and Jon Armstrong and Wirth, {Manfred P} and {Casodex Early Prostate Cancer Trialists' Group}",

year = "2006",

month = feb,

day = "1",

doi = "10.1111/j.1464-410X.2005.06051.x",

language = "English",

volume = "97",

pages = "247--54",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

AU - McLeod, David G

AU - Iversen, Peter

AU - See, William A

AU - Morris, Thomas

AU - Armstrong, Jon

AU - Wirth, Manfred P

AU - Casodex Early Prostate Cancer Trialists' Group

PY - 2006/2/1

Y1 - 2006/2/1

N2 - To evaluate, in the ongoing Early Prostate Cancer (EPC) trial programme, the efficacy and tolerability of bicalutamide 150 mg once daily in addition to standard care for localized or locally advanced, nonmetastatic prostate cancer.

AB - To evaluate, in the ongoing Early Prostate Cancer (EPC) trial programme, the efficacy and tolerability of bicalutamide 150 mg once daily in addition to standard care for localized or locally advanced, nonmetastatic prostate cancer.

U2 - 10.1111/j.1464-410X.2005.06051.x

DO - 10.1111/j.1464-410X.2005.06051.x

M3 - Journal article

C2 - 16430622

SN - 1464-4096

VL - 97

SP - 247

EP - 254

JO - BJU International

JF - BJU International

IS - 2

ER -

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

Abstract

Access to Document

Fingerprint

Cite this